Cryo-Cell International, Inc. (CCEL) Financials

CCEL Assets vs Liabilities

DateAssetsLiabilities
2024-02-29 61.7 million 72.0 million
2023-11-30 61.2 million 72.3 million
2023-08-31 69.8 million 69.8 million
2023-05-31 68.8 million 69.6 million

CCEL Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-02-29 -814587 307355
2023-11-30 1.4 million 174949
2023-08-31 -1.5 million 172099
2023-05-31 131657 156417

CCEL Net Income

No data available :(

CCEL Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-02-29 979593 - 1.0 million
2023-11-30 980250 - 1.1 million
2023-08-31 1.2 million - 1.1 million
2023-05-31 1.7 million - 1.2 million

CCEL Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-02-29 8.3 million
2023-11-30 8.3 million
2023-08-31 8.3 million
2023-05-31 8.3 million

CCEL Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-02-29 457722 502889 4.3 million -
2023-11-30 2.0 million 443808 5.4 million -
2023-08-31 3.4 million 344132 3.8 million -
2023-05-31 1.9 million 304682 4.0 million -

CCEL Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-02-29 7.9 million 2.2 million
2023-11-30 7.9 million 2.1 million
2023-08-31 7.9 million 2.2 million
2023-05-31 7.8 million 2.1 million

CCEL

Price: $8.63

52 week price:
3.41
8.93

Payout Ratio Range:
600.00%
9000.00%

Earnings Per Share: -1.14 USD

P/E Ratio: 17.22

Exchange: ASE

Sector: Healthcare

Industry: Medical Care Facilities

Volume: 6000

Market Capitalization: 63.8 million

Links: